It is an imbalanced agonist with GIPR potency close to native GIP but weaker GLP-1R affinity, and shows biased GLP-1R signaling, favoring cAMP over -arrestin recruitment
Precautions for Using the GLP-1 program The GLP-1 program should be used by one individual only
GLP-1 acts on the GLP-1R, activating multiple intracellular signaling pathways, including the cAMP/PKA pathway, the PI3K/Akt signaling pathway, and pathways related to anti-inflammatory and anti-oxidative stress responses, among others
Thyroid Cancer: As with other GLP-1 medications, animal studies have shown a theoretical risk of thyroid tumours
People in regions where telehealth or specific medications are restricted cannot use the full offering
As the program stands, states will have to issue a letter of intent before July 31, and then they will be invited to participate in the pricing agreement later